跳至主要内容
临床试验/NCT03878238
NCT03878238已完成不适用

Randomized, Double Blind and Placebo-controlled Pilot Study to Evaluate the Effect of a Probiotic Mixture in Acne Vulgaris

Bionou Research, S.L.2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2018年7月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25
试验地点
2
主要终点
Change from baseline in GAGS (Global Acne Grading System) index score at 12 weeks

研究概览

简要总结

A 12-week randomized, double-blind, placebo-controlled pilot study to evaluate the effect of a probiotic blend in the treatment and clinical and subjective evolution of acne vulgaris in adolescent and adult patients between 12 and 30 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
12 Years 至 30 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Signature of informed consent by the patient (and their legal guardian in case of being under age).
  • Age between 12 and 30 years-old.
  • Moderate acne according to the AGSS (Acne Global Severity Scale) and / or GAGS (Global Acne Grading System) scales.

排除标准

  • Contraindication of any of the components of the product under study.
  • Topical or systemic use of antifungals and antibiotics in the previous 2 weeks.
  • Consumption of probiotics in the previous 2 months.
  • Use of systemic retinoids in the previous 6 months.

研究组 & 干预措施

Placebo

Placebo Comparator

干预措施: Placebo (Other)

Probiotic

Experimental

干预措施: Probiotic Bths-003 (Dietary Supplement)

结局指标

主要结局

Change from baseline in GAGS (Global Acne Grading System) index score at 12 weeks

时间窗: 12-week

TOTAL SCORE = Nose S x 1 + Chin S x 1 + Front S x 2 + Right cheek S x 2 + Left cheek S x 2 + Torso S x 3 \[Severity (S): 0 = Absence; 1 = Comedones; 2 = Papules; 3 = Pustules; 4 = Nodules\] SCORE: 0 = Clean; 1-18 = Mild; 19-30 = Moderate; 31-38 = Severe; \> 38 = Very severe

次要结局

  • Number of acne lesions(0, 6 and 12-week)
  • Adherence to treatment(12-week)
  • Patient subjective evaluation(0, 6 and 12-week)
  • Treatment safety assessed by number of adverse events(12-week)
  • AGSS (Acne Global Severity Scale) index score(0, 6 and 12-week)

研究者

发起方
Bionou Research, S.L.
申办方类型
Network
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验